Sarissa Capital Acquisition Corp.

Sarissa Capital Acquisition Corp. (Nasdaq: SRSA) is a blank-check company sponsored by Sarissa Capital Management, the healthcare-focused activist investment firm led by Alex Denner. The SPAC completed its initial public offering in 2021 and targets opportunities in the biopharmaceutical and life sciences sector, drawing on Sarissa Capital's long track record of identifying and unlocking value in healthcare companies. As of its 10-Q filing dated May 13, 2022 (accession 0001193125-22-150259), the company had not yet announced a definitive business combination and remained in its search phase. Sign up on SpacDesk for full diligence data, filing history, and deal alerts on SRSA and hundreds of other active SPACs.